Af­ter months of back and forth, Mereo and its biggest stock­hold­er reach truce, re­place board mem­bers

For months, UK biotech Mereo Bio­Phar­ma has faced de­mands from its largest stock­hold­er Rubric Cap­i­tal Man­age­ment to shake up its board and ex­plore al­ter­na­tives for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER